RELAFEN
- Product NDC
- 73684-101
- 11-digit product format
- 736840101
- Labeler code
- 73684
- Product ID
- 73684-101_5353e546-6217-4761-94f8-b57c190c98c3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NABUMETONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BLUCREST PHARMACEUTICALS LLC
- Application
- ANDA203166
- Marketing category
- ANDA
- Marketing start
- 2020-06-01
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73684-101-30 | 73684010130 | 30 TABLET in 1 BOTTLE, PLASTIC (73684-101-30) | 30 tablet | 2020-06-01 | 0000-00-00 | No | No | Current |